dok7 gene therapy benefits mouse models diseases characterized defects neuromuscular junction
neuromuscular junction nmj synapse motor neuron skeletal muscle defects nmj transmission cause muscle weakness termed myasthenia muscle protein dok essential activation receptor kinase musk governs nmj formation dok7 mutations underlie familial limb-girdle myasthenia dok7 myasthenia neuromuscular disease characterized small nmjs show mouse model dok7 myasthenia therapeutic administration adeno-associated virus aav vector encoding human dok7 gene resulted enlargement nmjs substantial increases muscle strength life span applied model mice another neuromuscular disorder autosomal dominant emery-dreifuss muscular dystrophy dok7 gene therapy likewise resulted enlargement nmjs well positive effects motor activity life span results suggest therapies aimed enlarging nmj may useful range neuromuscular disorders
